ArticleAdvances in therapy2020

Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus.

Ona Kinduryte Schorling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.